Disposition of fluvoxamine in humans is determined by the polymorphic CYP2D6 and also by the CYP1A2 activity (Q71571828)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8823236%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

title

Disposition of fluvoxamine in humans is determined by the polymorphic CYP2D6 and also by the CYP1A2 activity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8823236%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

1 reference

Juan Antonio Carrillo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8823236%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

author name string

Dahl ML

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8823236%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

Svensson JO

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8823236%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

Alm C

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8823236%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

Rodríguez I

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8823236%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

Bertilsson L

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8823236%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

publication date

1 August 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8823236%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

19 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8823236%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

volume

60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8823236%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

page(s)

183-190

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8823236%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8823236%20AND%20SRC:MED&resulttype=core&format=json

Clinical pharmacokinetics of selective serotonin reuptake inhibitors

19 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990134-4

The role of cytochrome P4502D6 in the metabolism of paroxetine by human liver microsomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990134-4

Pharmacokinetics of the selective serotonin reuptake inhibitor paroxetine: Nonlinearity and relation to the sparteine oxidation polymorphism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990134-4

The relationship between paroxetine and the sparteine oxidation polymorphism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990134-4

Pharmacokinetics of citalopram in relation to the sparteine and the mephenytoin oxidation polymorphisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990134-4

Clinical pharmacokinetics of fluvoxamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990134-4

The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990134-4

Inhibition of alprazolam and desipramine hydroxylation in vitro by paroxetine and fluvoxamine: comparison with other selective serotonin reuptake inhibitor antidepressants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990134-4

Inhibition by fluoxetine of cytochrome P450 2D6 activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990134-4

Inhibition by paroxetine of desipramine metabolism in extensive but not in poor metabolizers of sparteine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990134-4

Fluvoxamine is a potent inhibitor of cytochrome P4501A2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990134-4

Selective serotonin reuptake inhibitors and theophylline metabolism in human liver microsomes: potent inhibition by fluvoxamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990134-4

Caffeine metabolism in a healthy Spanish population: N-acetylator phenotype and oxidation pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990134-4

Pronounced differences between native Chinese and Swedish populations in the polymorphic hydroxylations of debrisoquin and S-mephenytoin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990134-4

Polymorphic hydroxylation of Debrisoquine in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990134-4

Determination of debrisoquine and its 4-hydroxy metabolite in biological fluids by gas chromatography with flame-ionization and nitrogen-selective detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990134-4

A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990134-4

Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990134-4

Single and multiple oral dose fluvoxamine kinetics in young and elderly subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990134-4

The use of caffeine for enzyme assays: a critical appraisal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990134-4

Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990134-4

Caffeine as a metabolic probe: exploration of the enzyme-inducing effect of cigarette smoking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990134-4

Effect of cigarette smoking on fluvoxamine pharmacokinetics in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990134-4

Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990134-4

Comments to "interaction between caffeine and clozapine"

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990134-4

CYP1A2 activity, gender and smoking, as variables influencing the toxicity of caffeine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990134-4

Influence of patient-related variables on clozapine plasma levels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990134-4

Interaction between caffeine and clozapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990134-4

Use of caffeine metabolite ratios to explore CYP1A2 and xanthine oxidase activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990134-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0009-9236(96)90134-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8823236%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

1 reference